Literature DB >> 25890757

Multi-parametric hydrogels support 3D in vitro bioengineered microenvironment models of tumour angiogenesis.

Laura J Bray1, Marcus Binner2, Anja Holzheu2, Jens Friedrichs2, Uwe Freudenberg2, Dietmar W Hutmacher3, Carsten Werner2.   

Abstract

Tumour microenvironment greatly influences the development and metastasis of cancer progression. The development of three dimensional (3D) culture models which mimic that displayed in vivo can improve cancer biology studies and accelerate novel anticancer drug screening. Inspired by a systems biology approach, we have formed 3D in vitro bioengineered tumour angiogenesis microenvironments within a glycosaminoglycan-based hydrogel culture system. This microenvironment model can routinely recreate breast and prostate tumour vascularisation. The multiple cell types cultured within this model were less sensitive to chemotherapy when compared with two dimensional (2D) cultures, and displayed comparative tumour regression to that displayed in vivo. These features highlight the use of our in vitro culture model as a complementary testing platform in conjunction with animal models, addressing key reduction and replacement goals of the future. We anticipate that this biomimetic model will provide a platform for the in-depth analysis of cancer development and the discovery of novel therapeutic targets.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Carcinogenesis; Cell culture; ECM; Heparin; Hydrogel

Mesh:

Substances:

Year:  2015        PMID: 25890757     DOI: 10.1016/j.biomaterials.2015.02.124

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  52 in total

Review 1.  Tissue Engineering and Regenerative Medicine 2015: A Year in Review.

Authors:  Holly Wobma; Gordana Vunjak-Novakovic
Journal:  Tissue Eng Part B Rev       Date:  2016-02-23       Impact factor: 6.389

Review 2.  Heralding a new paradigm in 3D tumor modeling.

Authors:  Eliza L S Fong; Daniel A Harrington; Mary C Farach-Carson; Hanry Yu
Journal:  Biomaterials       Date:  2016-09-02       Impact factor: 12.479

3.  Perivascular signals alter global gene expression profile of glioblastoma and response to temozolomide in a gelatin hydrogel.

Authors:  Mai T Ngo; Brendan A C Harley
Journal:  Biomaterials       Date:  2018-06-13       Impact factor: 12.479

4.  Modular GAG-matrices to promote mammary epithelial morphogenesis in vitro.

Authors:  Mirko Nowak; Uwe Freudenberg; Mikhail V Tsurkan; Carsten Werner; Kandice R Levental
Journal:  Biomaterials       Date:  2016-10-06       Impact factor: 12.479

5.  A combined hiPSC-derived endothelial cell and in vitro microfluidic platform for assessing biomaterial-based angiogenesis.

Authors:  Sylvia L Natividad-Diaz; Shane Browne; Amit K Jha; Zhen Ma; Samir Hossainy; Yosuke K Kurokawa; Steven C George; Kevin E Healy
Journal:  Biomaterials       Date:  2018-11-28       Impact factor: 12.479

6.  The Influence of Hyaluronic Acid and Glioblastoma Cell Coculture on the Formation of Endothelial Cell Networks in Gelatin Hydrogels.

Authors:  Mai T Ngo; Brendan A Harley
Journal:  Adv Healthc Mater       Date:  2017-09-22       Impact factor: 9.933

Review 7.  Addressing Patient Specificity in the Engineering of Tumor Models.

Authors:  Laura J Bray; Dietmar W Hutmacher; Nathalie Bock
Journal:  Front Bioeng Biotechnol       Date:  2019-09-12

Review 8.  Angiogenic biomaterials to promote therapeutic regeneration and investigate disease progression.

Authors:  Mai T Ngo; Brendan A C Harley
Journal:  Biomaterials       Date:  2020-06-14       Impact factor: 12.479

Review 9.  Inspired by Nature: Hydrogels as Versatile Tools for Vascular Engineering.

Authors:  Ulrich Blache; Martin Ehrbar
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-07-01       Impact factor: 4.730

Review 10.  Glycosaminoglycan-Based Biohybrid Hydrogels: A Sweet and Smart Choice for Multifunctional Biomaterials.

Authors:  Uwe Freudenberg; Yingkai Liang; Kristi L Kiick; Carsten Werner
Journal:  Adv Mater       Date:  2016-07-27       Impact factor: 30.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.